Malignant Pleural Mesothelioma
Oncology
Prevalence
1.0 / 100K
Incidence
0.9 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Alimta® | ELI LILLY & Co (LLY) |
Frequently asked questions
How many drugs are in development for Malignant Pleural Mesothelioma?
BioSniper tracks 1 drug in development for Malignant Pleural Mesothelioma across 1 company.
How many clinical trials target Malignant Pleural Mesothelioma?
There are 2 clinical trials targeting Malignant Pleural Mesothelioma tracked by BioSniper.
What is the prevalence of Malignant Pleural Mesothelioma?
The estimated prevalence of Malignant Pleural Mesothelioma is approximately 1.0 per 100,000 population.
Deep-dive into Malignant Pleural Mesothelioma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis